Evidence map›Paper›PMID 36394259›Full record

ArticleeLife2022

Insulin sensitivity is preserved in mice made obese by feeding a high starch diet.

Amanda E Brandon, Lewin Small, Tuong-Vi Nguyen, Eurwin Suryana, Henry Gong, Christian Yassmin, Sarah E Hancock, Tamara Pulpitel, Sophie Stonehouse, Letisha Prescott and 7 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Amanda E Brandon *School of Medical Sciences, University of Sydney, Sydney, Australia.ORCID 0000-0002-4996-7189
Lewin Small *Diabetes and Metabolism Division, Garvan Institute of Medical Research, Sydney, Australia.ORCID 0000-0002-9767-9464
Tuong-Vi NguyenDiabetes and Metabolism Division, Garvan Institute of Medical Research, Sydney, Australia.
Eurwin SuryanaDiabetes and Metabolism Division, Garvan Institute of Medical Research, Sydney, Australia.
Henry GongSchool of Medical Sciences, University of Sydney, Sydney, Australia.
Christian YassminSchool of Medical Sciences, University of Sydney, Sydney, Australia.
Sarah E HancockDepartment of Pharmacology, School of Medical Sciences, University of New South Wales, Sydney, Australia.
Tamara PulpitelSchool of Life and Environmental Sciences, Charles Perkins Centre, University of Sydney, Sydney, Australia.
Sophie StonehouseSchool of Life and Environmental Sciences, Charles Perkins Centre, University of Sydney, Sydney, Australia.
Letisha PrescottSchool of Life and Environmental Sciences, Charles Perkins Centre, University of Sydney, Sydney, Australia.
Melkam A KebedeSchool of Life and Environmental Sciences, Charles Perkins Centre, University of Sydney, Sydney, Australia.ORCID 0000-0001-9686-7378
Belinda YauSchool of Life and Environmental Sciences, Charles Perkins Centre, University of Sydney, Sydney, Australia.
Lake-Ee QuekSchool of Mathematics and Statistics, Charles Perkins Centre, University of Sydney, Sydney, Australia.
Greg M KowalskiInstitute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Melbourne, Australia.
Clinton R BruceInstitute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Melbourne, Australia.ORCID 0000-0002-0515-3343
Nigel TurnerDepartment of Pharmacology, School of Medical Sciences, University of New South Wales, Sydney, Australia.
Gregory J CooneySchool of Medical Sciences, University of Sydney, Sydney, Australia.
The University of Sydney · AUGarvan Institute of Medical Research · AUDeakin University · AUUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity is generally associated with insulin resistance in liver and muscle and increased risk of developing type 2 diabetes, however there is a population of obese people that remain insulin sensitive. Similarly, recent work suggests that mice fed high carbohydrate diets can become obese without apparent glucose intolerance. To investigate this phenomenon further, we fed mice either a high fat (Hi-F) or high starch (Hi-ST) diet and measured adiposity, glucose tolerance, insulin sensitivity, and tissue lipids compared to control mice fed a standard laboratory chow. Both Hi-ST and Hi-F mice accumulated a similar amount of fat and tissue triglyceride compared to chow-fed mice. However, while Hi-F diet mice developed glucose intolerance as well as liver and muscle insulin resistance (assessed via euglycaemic/hyperinsulinaemic clamp), obese Hi-ST mice maintained glucose tolerance and insulin action similar to lean, chow-fed controls. This preservation of insulin action despite obesity in Hi-ST mice was associated with differences in de novo lipogenesis and levels of C22:0 ceramide in liver and C18:0 ceramide in muscle. This indicates that dietary manipulation can influence insulin action independently of the level of adiposity and that the presence of specific ceramide species correlates with these differences.

Indexed as

Diabetes Mellitus, Type 2Glucose IntoleranceInsulin ResistanceAnimalsCeramidesDiet, High-FatGlucoseInsulinMiceMice, ObeseObesityStarchCeramidesGlucoseInsulinStarchcell biologyceramideinsulin sensitivitymouseobesity

Identifiers

PMID36394259
PMCPMC9711519
OpenAlexW4309242817

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.